![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|12|4|361-367
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.4, 2012-12, pp. : 361-367
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Role of Gut Microbiota in Drug Response
Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of Yeasts in Healthy and Impaired Gut Microbiota: The Gut Mycome
Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)